Advanced Accelerator Applications (AAA) develops, produces and commercializes molecular nuclear medicine, diagnostic and therapeutic products in the fields of oncology (cancer), neurology, ...
Akero Therapeutics is providing treatment options for people with serious metabolic diseases like non-alcoholic steatohepatitis (NASH), a disease marked by inflammation in the liver and liver cell ...
AM–Pharma is a biopharmaceutical company developing proprietary recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to transform the treatment prospects for patients ...
Aminex Therapeutics, Inc., is a drug development company focused on discovery and development of a unique cancer drug therapy in the general category of cancer immunotherapies known as checkpoint ...
Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, ...
Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company primarily focused on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated ...
Biohaven is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
Bioventus is a global leader in orthobiologics. Through a combination of internal product development, product/business acquisition, and distribution agreements, we will bring to market products ...
Bioverativ will be an independent, publicly-traded, global biotechnology technology focused on the discovery, research, development and commercialization of therapies for hemophilia and other ...
CAMP4 has built a proprietary 4-D Gene Circuity Platform to codify the discrete set of combinatorial rules used by any human cell type central to disease pathology.
Cannabis Biotech conducts research to develop innovative cannabinoid products and therapies for the treatment of diseases and their symptoms. Ailments that the company has studied include HIV, ...
Cardurion is a recently launched, Boston-based cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases.
Develops novel compounds for cancer treatment. The most advanced product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor.
Casma Therapeutics is a preclinical-stage therapeutics company focused on modulating the autophagy pathway to address unmet medical needs and transform the lives of patients.
